MARKET

NBY

NBY

Novabay Pharma
AMEX
0.6080
-0.0010
-0.16%
After Hours: 0.6000 -0.008 -1.32% 19:58 03/28 EDT
OPEN
0.6070
PREV CLOSE
0.6090
HIGH
0.6151
LOW
0.6070
VOLUME
150.09K
TURNOVER
--
52 WEEK HIGH
9.08
52 WEEK LOW
0.3611
MARKET CAP
3.54M
P/E (TTM)
-0.0114
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at NBY last week (0317-0321)?
Weekly Report · 5d ago
Weekly Report: what happened at NBY last week (0310-0314)?
Weekly Report · 03/17 12:24
Weekly Report: what happened at NBY last week (0303-0307)?
Weekly Report · 03/10 12:26
NovaBay Plans To Hold Virtual Special Meeting On April 16, 2025, At Which Stockholders Will Vote On Proposal For Liquidation And Dissolution
Benzinga · 03/07 11:51
NovaBay Pharmaceuticals to Hold Special Meeting of Stockholders
Barchart · 03/07 05:50
Weekly Report: what happened at NBY last week (0224-0228)?
Weekly Report · 03/03 12:24
Weekly Report: what happened at NBY last week (0217-0221)?
Weekly Report · 02/24 12:25
Weekly Report: what happened at NBY last week (0210-0214)?
Weekly Report · 02/17 12:21
More
About NBY
NovaBay Pharmaceuticals, Inc. is engaged in wound care products. The Company manufactures and sells its proprietary form of hypochlorous acid for the wound care market through its NeutroPhase and PhaseOne branded products. NeutroPhase and PhaseOne are used for cleansing and irrigation as part of surgical procedures, as well as treating wounds, burns, ulcers and other injuries.
Recently
Symbol
Price
%Change
    NBY
  • 0.6080
  • -0.16%

Webull offers NovaBay Pharmaceuticals Inc stock information, including AMEX: NBY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NBY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NBY stock methods without spending real money on the virtual paper trading platform.